Crovalimab
An experimental complement inhibitor C5 monoclonal antibody.
patient
Treatment Approaches in AML: Key Testing for Personalized Care
VIDEO
Description:
Treatment Approaches in AML: Key Testing for Personalized Care from Patient Empowerment Network on Vimeo.
Talati Highlights “Game-Changing” Potential of Venetoclax/HMA Combos for Elderly AML
Chetasi Talati, MD, discusses early results from a multicenter chart review examining treatment patterns and outcomes of patients with newly diagnosed AML who received venetoclax/HMA combinations in the real-world setting and the next phase of the ongoing research initiative.
Chetasi Talati, MD
Chetasi Talati, MD
ASH Issues Guidelines on Newly Diagnosed AML in Older Adults
MDS Treatment, Inqovi: Dr. Amer Zeidan Explains the Use of this Treament
The recently-approved hypomethylating treatment, Inoqvi, is a daily oral version of two IV or subcutaneous medications. Listen to Dr. Amer Zeidan of Yale Cancer Center explain which MDS patients could qualify, and what it means for their treatment at the link.
FDA Grants Aspacytarabine Fast Track Status for Older Patients With AML
Stacy's Aplastic Anemia Journey Part 3: Disappointing Results from First Treatment
Person's Name:
Stacy Bravo
Since treatment in July 2019, I have still been transfusion-dependent, receiving both blood and platelets. I get so short of breath when my blood is low. I really hate this disease. Because I’m still transfusion-dependent, I go back and forth for labs, doctor’s appointments, and transfusions.
Bone Marrow Disease(s):
Content source:
Ivosidenib
Undiagnosed for Years, Josh Finally Finds both a Diagnosis and a Treatment!
Person's Name:
Joshua Maliczowski
Bone Marrow Disease(s):
Content source:
Cecilia Arana Yi, MD, MSHS, FACP
Arana Yi, Cecilia
Hematology/Oncology
Mayo Clinic, Phoenix, AZ
Online Profile: